The role of mast cells and basophils in inflammation

Clinical and Experimental Allergy, Supplement

Volumn 30, Issue 1, 2000, Pages 28-32

  Holgate, S T ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Basophils; Inflammatory mediators; Mast cells

Indexed keywords

CROMOGLYCATE DISODIUM;

ASTHMA; BASOPHIL; CELL FUNCTION; CELL PROLIFERATION; CONFERENCE PAPER; DRUG EFFECT; DRUG EFFICACY; ENZYME SPECIFICITY; HUMAN; INFLAMMATION; INFLAMMATORY CELL; MAST CELL; MEDIATOR RELEASE; PRIORITY JOURNAL; RECEPTOR AFFINITY; TARGET CELL;

ASTHMA; BASOPHILS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MAST CELLS;

EID: 0034089441     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Costa JJ, Galli SJ, Church K. Mast cell cytokines in allergic inflammation. In: Inflammatory Mechanisms in Asthma (eds Holgate ST, Busse WW), Lung Biology in Health and Disease (series ed. Lenfant C). New York: Marcel Dekker. Vol 117, 1998:111-28.
2. Walls AF, Shute JK, Warner J, Cairns JA, Howarth PH, Holgate ST. Mast cell and eosinophil proteases in the chronic allergic inflammatory response. In: Asthma, Physiology, Immunopharmacology and Treatment (eds Marone G, Austen KF, Lichtenstein L, Kay AB, Holgate ST). London: Academic Press, 1998:119-31.
3. Hon L, Howells GL, Kapas S, Macey MG. The protease-activated receptors and their cellular expression and function in blood-related cells. Br J Haematol 1998; 101:1-9.
4. Zhang S, Anderson DF, McGill JI, Holgate ST, Roche WR. Stem cell factor is synthesised and stored in human mast cells. J Path 1996; 179:37-43.
5. Ohkawara Y, Yamauchi K, Tanno Y et al. Human lung mast cells and pulmonary macrophages produce tumour necrosis factor α in sensitised lung tissue after IgE receptor triggering. Am J Respir Cell Mol Biol 1992; 7:385-92.
6. Montefort S, Holgate ST. Expression of cell adhesion molecules in asthma. In: Adhesion Molecules in Allergic Disease (ed Bochner BS). New York: Marcel Dekker, 1997: 315-38.
7. Coward WR, Sagara H, Church MK. Asthma, adenosine mast cells and theophylline. Clin Exp Allergy 1998; 28 (Suppl. 3):42-6.
8. Eggleston PA, Kagey-Sobotka A, Proud D, Adkinson NF, Lichtenstein LM. Dissociation of the release of histamine and arachidonic acid metabolites from osmotically activated basophils and human lung mast cells. Am Rev Respir Dis 1990; 141:960-4.
9. 4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. Thorax 1998; 52:1030-5.
10. 2B receptors: a novel therapeutic target in asthma? Trends Pharmacol Sci 1998; 19:148-153.
11. Altounyan REC. Inhibition of experimental asthma by a new compound - disodium cromoglycate 'Intal'. Acta Allerg 1967; 22:487.
12. Cox JSG. Disodium cromoglycate (FPL 670) ('Intal'): a specific inhibitor of reaginic antibody - antigen mechanisms. Nature (Lond) 1967; 216:1328-9.
13. Howell JBL, Altounyan REC. A double-blind trial of disodium cromoglycate in the treatment of allergic bronchial asthma. Lancet 1967; 2:539-42.
14. Eady RP, Norris AA. Nedocromil sodium and sodium cromoglycate: pharmacology and putative mode of action. In: Allergy and Allergic Diseases, Vol 1(ed. Kay AB). Oxford: Blackwell Science, 1997:584-95.
15. Holgate ST. Altounyan Address: Mediator and cytokine mechanisms in asthma. Thorax 1993; 48:103-9.
16. Corrcia I, Wang L, Pang X, Theoharides TC. Characterisation of the 78 kDa mast cell protein phosphorylated by the anti-allergic drug cromolyn and its homology to moesin. Biochem Pharmacol 1996:52:413-24.
17. Bell CJ, Davies DE, Lackie PM, Holgate ST. CD44 expression and ERM proteins. Interactions with epithelial growth factors in bronchial epithelial cell lines. BALR meeting on Respiratory Tract Epithelium. Respir Med 1998; 92:A18.
18. Chauhan AJ, Withers NJ, Krishna TM, Holgate ST. Cromones. In: Asthma: Basic Mechanisms and Clinical Practice, 3rd edn (eds Barnes PJ, Rodger IW, Thomson NC). London: Academic Press, 1998:707-24.
19. Holgate ST, Robinson C, Church MK. The contribution of mast cell mediators to acute allergic reactions in human skin and airways. Allergy 1998; 43 (Suppl. 5):22-31.
20. Okazaki H, Siraganian RP. Signal transduction for secretion in basophils. Allergy Clin Immunol Int 1999; 11:86-92.
21. Kimara T, Zhang J, Sagewa K, Sakaguchi K, Appella E, Siraganian R. Syk-independent tyrosine phosphorylation and association of the protein tyrosine phosphatase sHP-1 and sHP-2 with the high affinity IgE receptor. J Immunol 1997; 159:4426-34.
22. Holgate ST, Corne J, Jardieu P, Pick RB, Heusser CH. Treatment of allergic disease with anti-IgE. Allergy 1998; 53(Suppl. 45):83-8.
23. Boulet LP, Chapman KR, Cote J et al. Inhibitory effects of an anti-IgE antibody E-25 on allergen-induced early response. Am J Respir Crit Care Med 1997; 155:1835-40.
24. Fahy JV, Fleming HE, Wong HH et al. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 1997; 155:1828-34.
25. εR1 expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 1997; 158:1438-4.
26. Wenzel SE, Trudeau JB, Kaminsky DA, Cohn J, Martin RJ, Westcott JY. Effect of 5-lioxygenase inhibition on broncho-constriction and airway inflammation in nocturnal asthma. Am J Respir Crit Care Med 1995; 152:817-905.
27. Haslett C. Granulocyte apoptosis and inflammatory disease. Br Med Bull 1997; 53:669-83.